Your trusted source for investing success

Tag: pfizer

Top Pharmaceutical ETFs

Top Pharmaceutical ETFs

To help make investors aware of some of their options when looking at investing in the pharmaceutical sector, the Investing News Network took a look at the five top pharmaceutical ETFs.

BioSig Technologies Provides Shareholder Update

BioSig Technologies Provides Shareholder Update

BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address an unmet technology need for the $4 billion electrophysiology (EP) marketplace, today provided a shareholder update and highlighted the company’s recent achievements it has reached during the first part of

BioSig Technologies Completes Private Placement

BioSig Technologies Completes Private Placement

BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address an unmet technology need for the $4 billion electrophysiology (EP) marketplace, today announced the Company closed a private placement with proceeds of $4,349,953.50. Laidlaw & Co (UK) Ltd. in New

Naturally Splendid to Market Natera Hemp Protein 369 at Expo

Naturally Splendid to Market Natera Hemp Protein 369 at Expo

Naturally Splendid (TSXV:NSP) is pleased to announce it will be launching a first to the Canadian retail market, a HempOmega™ fortified protein blend under its NATERA® brand at the Canadian Health Food Association (“CHFA”) West Expo, in Vancouver on April 8th-9th 2017 in Vancouver.

What Are Inversion Deals?

What Are Inversion Deals?

Since losing the fight for healthcare reform, Trump’s administration has lost some momentum from companies and the market. It is possible Trump might change on this matter to gain back the goodwill of companies.

BioSig Technologies Announces Strategic Partnership with Mayo Clinic

BioSig Technologies Announces Strategic Partnership with Mayo Clinic

BioSig Technologies (OTCQB:BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address an unmet technology need for the $4 billion electrophysiology (EP) marketplace, today announced it has signed a ten-year strategic agreement with Mayo Clinic and Mayo Clinic Ventures. This new, expanded collaboration

Enter Your Log In Credentials
×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network